6505--Notice of Intent: PYLARIFY (piflufolastat F 18) Radiopharmaceutical Base plus 4 OY

NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office 21 (NCO 21) hereby gives notice of the Government s intent to order against the VA National Acquisition Center (NAC) contract 36F79719D0170 for a period of performance of a base plus four option year with Progenics Pharmaceuticals, Inc. for Pylarify prostate-specific membrane antigen (PSMA) positive emission tomography (PET) prostate cancer imaging agent deliveries at the VA Palo Alto Health Care System: 3801 Miranda Avenue, Palo Alto, CA 94304. Pylarify, (Piflufolastat F-18), is a radioactive diagnostic agent indicated for positive emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It can be used for men with suspected metastasis who are candidates for initial definitive therapy or those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.

Determination of this sole source procurement is in accordance with FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. It is the Government s belief that the proposed candidate is the only provider of PSMA PET prostate cancer imaging agent that can meet the agency s needs. The applicable North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing) and the Federal Supply Code (FSC) is 6505(Drugs and Biologicals).

This notice of intent is not a request for competitive quotes. Any business that believes it can provide the PSMA PET prostate cancer imaging agent for VA Palo Alto Health Care System may give written notice to moneque.rodriguez@va.gov by 3:00PM Hawaii Time on Thursday, March 17, 2022. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government.

THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.